Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Oral and Esophageal Aphthous Ulcers in HIV Patients
NCT00000790Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of thalidomide in aphthous stomatitis (RAS), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
thalidomide
03
Conditions
aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT00000790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000790.